NBE-P2

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameNBE-P2
Drug Alias NameNew Biological Entity P2
ClassificationBiologics > Protein drugs > Enzyme
Mechanisms of ActionTumor necrosis factor inhibitors
TargetsTumor necrosis factor
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDIREVO Biotech AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDIREVO Biotech AG
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A